Lexicon Pharmaceuticals Inc (LXRX)
0.827
+0.11
(+15.71%)
USD |
NASDAQ |
Dec 23, 16:00
0.81
-0.02
(-2.06%)
Pre-Market: 09:15
Lexicon Pharmaceuticals Shareholders Equity (Quarterly): 178.51M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viatris Inc | 19.79B |
| Halozyme Therapeutics Inc | 452.70M |
| Perspective Therapeutics Inc | 328.47M |
| Quanterix Corp | 336.75M |
| Autonomix Medical Inc | 3.028M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 321.12M |
| Total Liabilities (Quarterly) | 142.61M |
| Debt to Equity Ratio | 0.5596 |
| Current Ratio | 7.452 |
| Net Debt Paydown Yield | -0.04% |